IncyteCARES

IncyteCARES May Be Able to Help You Access Jakafi

IncyteCARES (Connecting to Access, Reimbursement, Education and Support) is a program designed to offer ongoing support and resources during your treatment with Jakafi. Whether you have an insurance question or just need to speak to a trained nurse regarding Jakafi, IncyteCARES is here to help.

Specifically, IncyteCARES offers:

  • Prescription insurance verification and prior authorization support
  • Free drug and co-pay assistance, for those who qualify
  • Referral to independent nonprofit organizations or foundations that may be able to provide financial assistance
  • Access to oncology nurses

IncyteCARES (Connecting to Access, Reimbursement, Education and Support)

The objective of IncyteCARES is to help patients gain access to Jakafi. Based on patients enrolled in the program between April 1, 2012, and August 31, 2013:

94%
of patients referred to the co-pay assistance program were eligible for assistance
96%
of prior authorizations were approved for Jakafi

Enroll in IncyteCARES

Learn how to enroll in the IncyteCARES program.

Have a comment or question about IncyteCARES?

We welcome your feedback.

 An IncyteCARES specialist may contact me regarding my question or comment.

Indication

Jakafi is a prescription medicine used to treat people with intermediate or high-risk myelofibrosis (MF), including primary MF, post–polycythemia vera (PV) MF, and post–essential thrombocythemia (ET) MF.

Important Safety Information

Jakafi can cause serious side effects including:

Low blood counts: Jakafi may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you experience unusual bleeding, bruising, fatigue, shortness of breath, or a fever.

Infection: You may be at risk for developing a serious infection while taking Jakafi. Tell your healthcare provider if you develop symptoms such as chills, nausea, vomiting, aches, weakness, fever, or painful skin rash or blisters.

The most common side effects of Jakafi include dizziness and headache.

These are not all the possible side effects of Jakafi. Ask your healthcare provider or pharmacist for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Before taking Jakafi, tell your healthcare provider about all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had liver or kidney problems, are on dialysis, or have any other medical condition. Do not drink grapefruit juice while taking Jakafi.

Women should not take Jakafi while pregnant or planning to become pregnant, or if breast-feeding.

Please see Full Prescribing Information, which includes a more complete discussion of the risks associated with Jakafi.